Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: Psychiatry Res. 2023 Dec 21;331:115686. doi: 10.1016/j.psychres.2023.115686

Table 2.

Stimulant Prescribing in Long-COVID and Comparison Cohorts

Long-COVID Cohort Comparison Cohort
N
56,273		 % N
189,438		 %
Total (Any Stimulant) 790 1.40 1,266 0.67
 Amphetamine* 200 0.36 352 0.19
 Armodafinil 13 0.02 21 0.01
 Dexmethylphenidate 13 0.02 20 0.01
 Dextroamphetamine 142 0.25 221 0.12
 Lisdexamphetamine 107 0.19 196 0.10
 Methamphetamine 31 0.06 50 0.03
 Methylphenidate 193 0.34 291 0.15
 Modafinil 91 0.16 115 0.06
*

Includes Dextroamphetamine/Amphetamine salts